AER Toll-Free Number Proposed Rule Targeted For September Release
This article was originally published in The Tan Sheet
Executive Summary
The targeted action date for a proposed rule requiring the labeling of human drugs to carry a toll-free number for reporting adverse events has been pushed back to September, according to FDA's semi-annual "1unified agenda.
You may also be interested in...
Dietary Supplement “Flexible” Testing Requirements Proposed In GMPs
FDA's proposed good manufacturing practices for dietary supplements would require final product testing for adherence to identity, purity, quality, strength and composition specifications unless a scientifically valid analytical method does not exist
ANDA Bioequivalence Data Subject Of Upcoming FDA Proposed Rule
FDA expects to issue an advance notice of proposed rulemaking in November requiring ANDA applicants to include data from all bioequivalence studies conducted on a drug formulation with their application
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC